Related Experiment Video
Updated: Oct 8, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Gastrointestinal malacoplakia in children
Insights
Malacoplakia in children, a rare gastrointestinal condition, often presents with severe symptoms. Long-term antibiotic and cholinergic agonist treatment may improve outcomes, though responses can be unpredictable.
Area of Science:
- Pediatric Gastroenterology
- Rare Gastrointestinal Diseases
Background:
- Malacoplakia is a rare chronic inflammatory condition.
- Gastrointestinal malacoplakia is particularly uncommon in pediatric patients.
Observation:
- Four pediatric patients (ages 1-13) with gastrointestinal malacoplakia were treated.
- Patients often had coexisting chronic illnesses.
- Symptoms included bloody diarrhea, abdominal pain, fever, and malnutrition.
Findings:
- Colonoscopy revealed inflamed, friable mucosa with ulcerations and pseudopolyposis.
- Treatment involved antibiotics and cholinergic agonists.
- Three of four patients showed favorable responses to long-term therapy.
Implications:
- Early diagnosis and sustained treatment are crucial for managing pediatric gastrointestinal malacoplakia.
- While treatment response is variable, prolonged therapy can lead to positive outcomes.
- Further research into optimal therapeutic strategies for this rare condition is warranted.
Abstract:
Four children, whose ages ranged from 1 to 13 years, with malacoplakia of the gastrointestinal tract were treated at King Faisal Specialist Hospital between 1979 and 1983. All patients had either a preceding or a coexisting chronic illness. In one patient, malacoplakia was an incidental finding, while the remaining three patients presented with bloody diarrhea, abdominal pain, recurrent fever, and severe malnutrition. Colonoscopy in two patients revealed markedly inflamed and friable mucosa with focal ulceration alternating with patches of normal mucosa and pseudopolyposis. They were treated with antibiotics and cholinergic agonists. Three patients responded favorably, while one patient continued to have extensive active disease. Although the response to therapy is unpredictable, patients may respond if the treatment is continued on a long-term basis.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Fungal Phylum Microsporidia
Peptic Ulcer
Giardiasis
Esophageal Achalasia
Gastritis II: Pathophysiology

